# A Study of CLE-400 (Topical Gel) for the Treatment of Chronic Pruritus in Adult Subjects With Notalgia Paresthetica

> **NCT06262607** · PHASE2 · COMPLETED · sponsor: **Clexio Biosciences Ltd.** · enrollment: 59 (actual)

## Conditions studied

- Chronic Pruritus in Adult Subjects With Notalgia Paresthetica (NP)

## Interventions

- **DRUG:** CLE-400
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT06262607
- **Lead sponsor:** Clexio Biosciences Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-29
- **Primary completion:** 2024-11-06
- **Final completion:** 2024-11-19
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2025-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06262607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06262607, "A Study of CLE-400 (Topical Gel) for the Treatment of Chronic Pruritus in Adult Subjects With Notalgia Paresthetica". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06262607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*